Profile
Charles M. Baum appears in SEC filings associated with Acrivon Therapeutics, Inc. as of May 20, 2026. Publicly available information beyond the SEC context is limited, and his specific role (e.g., officer, director, or other insider) is not clearly disclosed in the provided context. Based on the SEC filing context, he is a corporate insider connected to a public biotech company in 2026.
| Role | Insider |
|---|
| Notability | 34/100 |
|---|
Board memberships
- Acrivon Therapeutics, Inc.
Awards & honors
- Listed in SEC filings related to Acrivon Therapeutics, Inc. as of 2026-05-20.
Frequently Asked Questions
Who is BAUM CHARLES M?
Charles M. Baum appears in SEC filings associated with Acrivon Therapeutics, Inc. as of May 20, 2026. Publicly available information beyond the SEC context is limited, and his specific role (e.g., officer, director, or other insider) is not clearly disclosed in the provided context. Based on the SEC filing context, he is a corporate insider connected to a public biotech company…
How many SEC Form 4 filings has BAUM CHARLES M submitted recently?
3 primary Form 4 filings in the last 90 days, covering 2 companies.
Where can I see all of BAUM CHARLES M's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.